Ivar P. Gladhaug - Search Results

Year	Number of Results
2003	1
2006	2
2007	2
2008	3
2009	3
2010	3
2011	4
2012	6
2013	5
2014	5
2015	6
2016	9
2017	5
2018	2
2019	5
2020	5
2021	2
2022	1
2023	3
2024	1

1

Pancreatic Cancer Chemoresistance to Gemcitabine.

Amrutkar M, Gladhaug IP. Amrutkar M, et al. Among authors: gladhaug ip. Cancers (Basel). 2017 Nov 16;9(11):157. doi: 10.3390/cancers9110157. Cancers (Basel). 2017. PMID: 29144412 Free PMC article. Review.

2

Dissection of Pancreatic Resection Specimens.

Verbeke CS, Gladhaug IP. Verbeke CS, et al. Surg Pathol Clin. 2016 Dec;9(4):523-538. doi: 10.1016/j.path.2016.05.001. Epub 2016 Oct 13. Surg Pathol Clin. 2016. PMID: 27926357 Review.

3

Minneord: Johannes Setekleiv.

Gladhaug IP, Skomedal T, Mørland J, Christoffersen T, Osnes JB. Gladhaug IP, et al. Tidsskr Nor Laegeforen. 2017 Aug 21;137(14-15). doi: 10.4045/tidsskr.17.0518. Print 2017 Aug 22. Tidsskr Nor Laegeforen. 2017. PMID: 28828823 Free article. Norwegian. No abstract available.

4

Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis.

Amrutkar M, Berg K, Balto A, Skilbrei MG, Finstadsveen AV, Aasrum M, Gladhaug IP, Verbeke CS. Amrutkar M, et al. Among authors: gladhaug ip. Cancer Cell Int. 2023 Jan 19;23(1):9. doi: 10.1186/s12935-023-02852-7. Cancer Cell Int. 2023. PMID: 36658582 Free PMC article.

5

Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells.

Li Y, Amrutkar M, Finstadsveen AV, Dalen KT, Verbeke CS, Gladhaug IP. Li Y, et al. Among authors: gladhaug ip. Cancer Cell Int. 2023 Nov 17;23(1):276. doi: 10.1186/s12935-023-03138-8. Cancer Cell Int. 2023. PMID: 37978383 Free PMC article.

6

Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.

Haugvik SP, Kaemmerer D, Gaujoux S, Labori KJ, Verbeke CS, Gladhaug IP. Haugvik SP, et al. Curr Oncol Rep. 2016 May;18(5):28. doi: 10.1007/s11912-016-0518-9. Curr Oncol Rep. 2016. PMID: 26984415 Review.

7

Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer.

Amrutkar M, Gladhaug IP. Amrutkar M, et al. Among authors: gladhaug ip. Cancers (Basel). 2021 Feb 3;13(4):601. doi: 10.3390/cancers13040601. Cancers (Basel). 2021. PMID: 33546284 Free PMC article. Review.

8

Pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors.

Haugvik SP, Labori KJ, Waage A, Line PD, Mathisen Ø, Gladhaug IP. Haugvik SP, et al. J Gastrointest Surg. 2013 Jul;17(7):1224-32. doi: 10.1007/s11605-013-2221-6. Epub 2013 May 14. J Gastrointest Surg. 2013. PMID: 23670519 Review.

9

Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.

Haugvik SP, Labori KJ, Edwin B, Mathisen Ø, Gladhaug IP. Haugvik SP, et al. ScientificWorldJournal. 2012;2012:357475. doi: 10.1100/2012/357475. Epub 2012 Dec 10. ScientificWorldJournal. 2012. PMID: 23304085 Free PMC article. Review.

10

Risk for hemorrhage after pancreatoduodenectomy with venous resection.

Kleive D, Sahakyan M, Søreide K, Brudvik KW, Line PD, Gladhaug IP, Labori KJ. Kleive D, et al. Among authors: gladhaug ip. Langenbecks Arch Surg. 2018 Dec;403(8):949-957. doi: 10.1007/s00423-018-1721-y. Epub 2018 Nov 5. Langenbecks Arch Surg. 2018. PMID: 30397778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

64 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year